21 CFR § 1.1440 - What process will FDA follow when waiving a requirement of this subpart on our own initiative?
---identifier: "/us/cfr/t21/s1.1440"source: "ecfr"legal_status: "authoritative_unofficial"title: "21 CFR § 1.1440 - What process will FDA follow when waiving a requirement of this subpart on our own initiative?"title_number: 21title_name: "Food and Drugs"section_number: "1.1440"section_name: "What process will FDA follow when waiving a requirement of this subpart on our own initiative?"chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"subchapter_number: "A"subchapter_name: "GENERAL"part_number: "1"part_name: "GENERAL ENFORCEMENT REGULATIONS"positive_law: falsecurrency: "2026-04-05"last_updated: "2026-04-05"format_version: "1.1.0"generator: "[email protected]"authority: "15 U.S.C. 1333, 1453, 1454, 1455, 4402; 19 U.S.C. 1490, 1491; 21 U.S.C. 321, 331, 332, 333, 334, 335a, 342, 343, 350c, 350d, 350j, 352, 355, 360b, 360ccc, 360ccc-1, 360ccc-2, 362, 371, 374, 381, 382, 384a, 387, 387a, 387c, 393, and 2223; 42 U.S.C. 216, 241, 243, 262, 264, 271."regulatory_source: "42 FR 15553, Mar. 22, 1977, unless otherwise noted."cfr_part: "1"---
Identifier
/us/cfr/t21/s1.1440
Currency
2026-04-05
Positive Law
No
Updated
2026-04-05
Chapter
Food and Drug Administration, Department of Health and Human Services
# 1.1440 What process will FDA follow when waiving a requirement of this subpart on our own initiative?(a) If FDA, on our own initiative, determines that a waiver of one or more requirements for an individual entity or type of entity is appropriate, we will publish a notice in the *Federal Register* setting forth the proposed waiver and the reasons for such waiver. The notice will establish a public docket so that interested persons may submit written comments on the proposal.(b) After considering any comments timely submitted, we will publish a notice in the *Federal Register* stating whether we are granting the waiver (in whole or in part) and the reasons for our decision.(c) Any waiver for a type of entity that FDA grants will become effective on the date that notice of the waiver is published in the *Federal Register,* unless otherwise stated in the notice.